Manufacturing

We are committed to improving the global affordability of medicines by investing in our manufacturing facilities, which adhere to cGMP standards and are globally approved

API

Our API legacy spans over years, during which we have served the world’s largest pharmaceutical companies with generic and complex APIs. We are committed to maintaining this legacy by investing in our manufacturing capital and adhering to globally approved cGMP standards.

We point to enhance our API R&D and manufacturing capabilities in therapeutic areas such as Growth Hormones, GLP-1 Against Receptor, etc. Our APIs cover a wide range of therapeutic categories, with over 30 medicines. We are also increasing our filings for regulated markets, with a robust pipeline of over 50 APIs at various stages of development.

Sustainability

Levo Pharma is dedicated to delivering high-quality products to customers. To fulfill this commitment, we have implemented current good manufacturing practices across our manufacturing sites. This implementation allows us to uphold consistent quality, efficiency, and product safety

Capitalizing on India’s competitive cost base and a skilled team of scientists, we have successfully introduced a range of cost-effective products accessible globally. Our growth is supported by efficient drug development and substantial manufacturing, from discovery to commercialization.